MAAT INDEX

CLAIM #23059 · EMR (EMR) · 2026Q2 earnings call · May 5, 2026 · due Sep 30, 2026

And also I think that is an important addition to your statement. Sequential growth mid-single digit is consistent with year-over-year mid-single digit, and if you do the math, the leverage will be a tad better than the 30s you stated for the second half.

Michael Baughman · CFO

PENDING
graded after results covering Sep 30, 2026 are reported

How to check this claim

Look at: Sequential revenue growth (quarter-over-quarter) and incremental operating margin leverage for the second half of fiscal 2026

It came true if: Sequential growth in the mid-single-digit percent range (approximately 4-6%) each quarter, with second-half incremental margin leverage modestly above 30% (e.g., 31-35%)

Where: Company quarterly income statement and management commentary on Q3/Q4 FY2026 earnings calls

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2026Q2 earnings call.